Obesity without the health problems? There could be a way

Obesity is linked to the widespread epidemics of diabetes and heart disease that plague society, but a lesser-known fact is that the weight can also lead to autoimmune disease. Now, researchers have new information about how that damaging immune response happens and how it might be stopped, published on April 4 in Cell Reports.

The key, they show, may be to block an important element known as AIM (for apoptosis inhibitor of macrophage) in the bloodstream and, ultimately, the production of antibodies that attack the self.

The discovery is especially notable because the team of researchers, from the University of Tokyo and led by Toru Miyazaki, previously discovered AIM, linking it to the inflammation that comes with obesity. They also showed that its suppression could help prevent obesity-associated diabetes and atherosclerosis. Their new work extends those benefits of AIM suppression to include autoimmune disease.

"Our report for the first time explains how obesity causes an initial , namely production of multiple antibodies against self-antigens, and also defines a key molecule in this autoimmune process," Miyazaki said.

The researchers found that a natural immunoglobulin called IgM rises in the blood of mice fed on a high-fat diet. The rise in IgM results as stimulate particular . Furthermore, IgM binds to AIM, and this complex is retained in the blood rather than excreted in urine. The researchers propose that the prolonged presence of IgM-AIM in the blood may contribute to the production of auto-antibodies. Correspondingly, they find that lacking AIM are protected from that harmful autoimmune response.

"Suppression of AIM appears to intercept two different obesity-associated pathological immune responses, namely, based on innate immunity and autoantibody production based on humoral immunity," the researchers wrote. "Thus, AIM inhibition potentially could be used as a therapy to prevent not only insulin resistance and metabolic disorders but also autoimmunity under obese conditions."

Miyazaki's team says that human studies are needed to pursue the development of a new AIM-targeted obesity therapy.

More information: Cell Reports, Arai et al.: "Obesity-associated autoantibody production requires AIM to retain IgM immune complex on follicular dendritic cells." dx.doi.org/10.1016/j.celrep.2013.03.006

Related Stories

Immune cell death safeguards against autoimmune disease

Sep 06, 2012

Researchers at the Walter and Eliza Hall Institute have discovered that a pair of molecules work together to kill so-called 'self-reactive' immune cells that are programmed to attack the body's own organs. ...

Keeping the immune system from starting a 'food fight'

May 03, 2007

After every meal, the body must prevent the immune system from launching an all-out fight against food. Now, researchers report the identity of a nutrient "floodgate" that serves to protect against such an inflammatory immune ...

Recommended for you

Nearly 30% of world population is overweight: study

Nov 20, 2014

More than 2.1 billion people globally—or nearly 30 percent of the world's population—are now overweight or obese, with the figure set to rise further by 2030, according to a study published Thursday.

Report: Global obesity costs hits $2 trillion

Nov 20, 2014

The global cost of obesity has risen to $2 trillion annually—nearly as much as smoking or the combined impact of armed violence, war and terrorism, according to a new report released Thursday.

Small cash rewards pay off in weight loss plans

Nov 20, 2014

People who received small cash bonuses for their degree of participation in an Internet weight loss program shed more pounds than those who were not offered bonuses and they kept much of the weight off, according to a new ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.